BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6585590)

  • 1. Antitumor effect, cardiotoxicity, and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing LOU/M/WSL rat.
    van Hoesel QG; Steerenberg PA; Vos JG; Hillen FC; Dormans JA
    J Natl Cancer Inst; 1984 May; 72(5):1141-50. PubMed ID: 6585590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
    van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
    J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
    van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
    Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations.
    de Wildt DJ; de Jong Y; Hillen FC; Steerenberg PA; van Hoesel QG
    J Pharmacol Exp Ther; 1985 Oct; 235(1):234-40. PubMed ID: 4045723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
    Storm G; van Hoesel QG; de Groot G; Kop W; Steerenberg PA; Hillen FC
    Cancer Chemother Pharmacol; 1989; 24(6):341-8. PubMed ID: 2791187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
    Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
    Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats.
    Ibrahim MA; Morsy MA; Hafez HM; Gomaa WM; Abdelrahman AM
    Toxicol Mech Methods; 2012 Jul; 22(6):424-31. PubMed ID: 22394338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
    Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat.
    Russo S; Filippelli W; Ferraraccio F; Berrino L; Guarino V; Rossi F
    J Med; 1994; 25(1-2):65-89. PubMed ID: 7930959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm in Bence-Jones protein excretion by LOU rats bearing a transplantable immunocytoma, responsive to adrimycin treatment.
    Nelson W; Zinneman H; Selden J; Schaper K; Halberg F; Bazin H
    Int J Chronobiol; 1974; 2(4):359-65. PubMed ID: 4219403
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin.
    Monti E; Paracchini L; Piccinini F; Rossi C; Formelli F
    Cancer Lett; 1990 Apr; 50(1):79-85. PubMed ID: 2353985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
    Osman AM; Nemnem MM; Abou-Bakr AA; Nassier OA; Khayyal MT
    Food Chem Toxicol; 2009 Oct; 47(10):2425-30. PubMed ID: 19577608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.